Healthcare -
Biotechnology - NASDAQ - CA
$ 37.24
9.88 %
$ 262 M
Market Cap
-266.0
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Bright Minds Biosciences Inc.
| Net Income | -2.8 M |
| Depreciation & Amortization | 73.4 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 840 K |
| Change in Working Capital | 39.8 K |
| Others | 38.6 K |
| Free Cash Flow | -1.85 M |
Cash Flow
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (2.8) | (7.4) | (15.0) | (8.7) | (0.5) | 78.7 K |
| Depreciation & Amortization | 73.4 K | 72.4 K | 6.04 K | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.8 | 1.2 | 0.9 | 0.9 | 0.2 | 0 |
| Other Operating Activities | 1.18 K | 65.1 K | (0.2) | 0.1 | 0.2 | 0.1 |
| Change in Working Capital | 39.8 K | (0.9) | 0.7 | 0.3 | 30.7 K | 36.7 K |
| Cash From Operations | (1.9) | (7.0) | (13.6) | (7.3) | (0.3) | 42 K |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | 0 | 5 | 0 | 0 | 0 | 0 |
| Other Items | 0 | 5 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 89.7 K | 86.1 K | 7.16 K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 302 | 1.1 | 1.2 | (1.7) | 0 | 0.4 |
| Cash From Financing Activities | 0.8 | 2.2 | 5.2 | 26.1 | 1.0 | 0.1 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (1.0) | (4.9) | (8.1) | 19.0 | 0.7 | 80 K |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (1.9) | (7.0) | (13.6) | (7.3) | (0.3) | 42 K |